SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,808 | -34.8% | 2,250 | -12.6% | 0.01% | -33.3% |
| Q2 2023 | $11,974 | +0.6% | 2,575 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $11,897 | -45.0% | 2,575 | -3.7% | 0.01% | -43.8% |
| Q4 2022 | $21,614 | -1.8% | 2,675 | -32.7% | 0.02% | -15.8% |
| Q3 2022 | $22,000 | -8.3% | 3,975 | -13.1% | 0.02% | 0.0% |
| Q2 2022 | $24,000 | -36.8% | 4,575 | 0.0% | 0.02% | -24.0% |
| Q1 2022 | $38,000 | -44.1% | 4,575 | 0.0% | 0.02% | -41.9% |
| Q4 2021 | $68,000 | -35.8% | 4,575 | -18.4% | 0.04% | -44.9% |
| Q3 2021 | $106,000 | +3.9% | 5,608 | +2.6% | 0.08% | +4.0% |
| Q2 2021 | $102,000 | +251.7% | 5,466 | +325.4% | 0.08% | +226.1% |
| Q1 2021 | $29,000 | +93.3% | 1,285 | +87.3% | 0.02% | +76.9% |
| Q4 2020 | $15,000 | – | 686 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |